The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder

Chemical Research in Toxicology

Volumn 14, Issue 7, 2001, Pages 767-790

  Hoffmann, D ^a   Hoffmann, I ^a   El Bayoumy, K ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKENE; CARBON MONOXIDE; HYDROGEN CYANIDE; NICOTINE; NITROGEN OXIDE; VOLATILE AGENT;

CARCINOGENICITY; CIGARETTE SMOKING; DISEASE ASSOCIATION; HEALTH CARE POLICY; HUMAN; LUNG CANCER; PREVALENCE; REVIEW; SMOKING HABIT; TOBACCO INDUSTRY;

ANIMALS; CARCINOGENS; FILTRATION; HISTORY, 20TH CENTURY; HUMANS; SMOKING; TOBACCO; TOBACCO SMOKE POLLUTION;

CRICETINAE; NICOTIANA TABACUM;

EID: 0034917171     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx000260u     Document Type: Review

References (227)

1. Tobacco smoking
2. Cancer statistics
3. Effect of smoking on the incidence and mortality of lung cancer
4. Smoking-attributable cancer mortality in 1991: Is lung cancer now the leading cause of death among smokers in the United States?
5. Mortality from smoking worldwide
6. Nutrition and tobacco-related cancer
7. U.S. Tob. statistics, 1935-92
8. Cigars. Health effects and trends
9. Tobacco use among middle and high school students - United States, 1999
10. The changing cigarette, 1950-1995
11. Some practical aspects of the smoking and cancer problem
12. Safer cigarettes
13. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. A study of six hundred and eighty-four proven cases
14. Smoking and carcinoma of the lung: Preliminary report
15. Experimental production of carcinoma with cigarette tar
16. A study of tobacco carcinogenesis. II. Dose-response studies
17. Investigation of the effects of chronic cigarette smoke inhalation in Syrian golden hamsters
18. The chemical constituents of tobacco and tobacco smoke
19. The chemical composition of tobacco and tobacco smoke
20. Natural tobacco flavor
21. The tobacco chemists' research conference; A half-century of advances in analytical methodology of tobacco and its products
22. The presence of 3,4-benzopyrene in cigarette smoke
23. On the analysis of vinyl chloride in cigarette smoke
24. An international survey of "IARC group I carcinogens" reported in mainstream cigarette smoke
25. "IARC group 2A carcinogens" reported in cigarette mainstream smoke
26. "IARC group 2B carcinogens" reported in cigarette mainstream smoke
27. The changing cigarette, 1950-1997. Facts and expectations
28. Chemical carcinogenesis
29. A study of tobacco carcinogenesis. VII. The role of higher polycyclic hydrocarbons
30. Chemical studies on tobacco smoke. LXII. Assessment of tobacco-specific N-nitrosamines in tobacco products
31. Tobacco-specific N-nitrosamines and arecaderived N-nitrosamines. Chemistry, biochemistry, carcinogenicity, and relevance to humans
32. A study of tobacco carcinogenesis. LII. Carcinogenicity of XI′-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mink (Mustala Vison)
33. Inhibition of mutagenicity of N-nitrosamines by tobacco smoke and its constituents
34. Effect of nicotine and cotinine on metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver. Naunyn-schmiedebergs
35. A study of tobacco carcinogenesis. L. The effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats
36. The identification of 11β-hydroxysteroid dehydrogenase as carboxyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
37. A study of tobacco carcinogenesis. XXXIV, Effect of snuff and nicotine on DNA methylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
38. Nature of cigarette smoke. Technique of cigarette smoking
39. Tar and nicotine in cigarette smoke
40. The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of U.S. cigarettes. Report of the NCI expert committee
41. Recent changes in tobacco products and their acceptance by the consumer
42. Filtration of smoke particles
43. Effect of filtration on chemical and irritating properties of cigarette smoke
44. Cilia toxic components of cigarette smoke
45. Components of cigarette smoke with ciliary depressant activity and their selective removal by filters containing activated charcoal granules
46. Cigarette smoke and cilia stasis. Effect of varying composition of smoke
47. Cilia toxic components in cigarette smoke. III. In vitro comparison of different smoke components
48. Japan always something new
49. Filtering new technology
50. Filtration of phenols from cigarette smoke
51. Selective filtration of volatile phenolic compounds from cigarette smoke
52. The selective filtration of tobacco smoke
53. Tumor-promoting action of phenol and related compounds from mouse skin
54. Chemical studies on tobacco smoke. XVII. Assessment of carcinogenic volatile N-nitrosamines in tobacco and in mainstream and sidestream smoke from cigarettes
55. The effect of perforated tipping paper on the yields of various smoke components
56. The effect of tip dilution on the filtration efficiency of upstream and downstream segments of cigarette filters
57. The effect of ventilation on cigarette combustion mechanisms
58. Effect of cigarette paper on smoke yield and composition
59. Low ignition propensity cigarettes: Smoke analysis for carcinogens and testing for mutagenic activity of the smoke particulate matter
60. Characterization of tobacco products: A comparative study of the tar, nicotine, and carbon monoxide yields of cigars, manufactured cigarettes, and cigarettes made from fine-cut tobacco
61. How hand-rollers assert personality in Britain
62. Alteration of cigarette smoke composition. II. Influence of cigarette design
63. Role of cigarette physical characteristics on smoke composition
64. The effect of cigarette construction parameters on smoke generation and yield
65. Untersuchungen über den nitratgehalt des tabaks
66. Simple correlation and multiple regression among leaf and smoke characteristics of burley tobaccos
67. Chemical and physical criteria for tobacco leaf of modern day cigarettes
68. Changes in cigarette design and composition over time and how they influence the yields of smoke constituents
69. x and HCN levels in mainstream and sidestream smoke
70. The presence of nitrous oxide and methyl nitrite in cigarette smoke and tobacco pyrolysis gases
71. Nitrogen fertilization and genotype effects of selected constituents from allburley cigarettes
72. Nitrosamine formation from precursors in tobacco smoke
73. The role of tobacco stems in the formation of N-nitrosamines in tobacco and cigarette mainstream and sidestream smoke
74. Ein experimenteller beitrag zur tabakcancerogenese
75. Chemical studies on tobacco smoke. III. Primary and secondary nitroalkanes in cigarette smoke
76. Tobacco smoking, chewing, and snuff dipping. Factors contributing to the endogenous formation of N-nitroso compounds
77. Chemical studies on tobacco smoke. LXIV. On the analysis of aromatic amines in cigarette smoke
78. Intercept-reactant method for the determination of aromatic amines in mainstream tobacco smoke
79. Chemical studies on tobacco smoke. XXV. The pH of tobacco smoke
80. Absorption of nicotine in cigarette and cigar smoke through the oral mucosa
81. Health risks associated with cigar smoking
82. The reduction of the tumorigenicity of cigarette smoke condensate by addition of sodium nitrate to tobacco
83. Effect of reconstitution and expansion processes on smoke composition
84. Reduction of tumorigenicity of tobacco smoke. An experimental approach
85. Distribution of tobacco constituents in tobacco leaf tissue. I. Tobacco-specific nitrosamines, nitrate, nitrite, and alkaloids
86. Analytical studies on N-nitrosamines in tobacco and tobacco smoke
87. Tobacco encyclopedia
88. Ethylene oxide. IARC monographs on the evaluation of the carcinogenic risks of chemicals to humans
89. Bestimmung von äthylenoxid im rauch garantiert unbegaster zigaretten
90. Ethylene. IARC monograph on the evaluation of carcinogenic risks of chemicals to humans
91. Column elution of humectants from tobacco and determination by vapor chromatography
92. Direct vapor chromatographic determination of menthol, propylene glycol, nicotine and triacetin in cigarette smoke
93. Propylene oxide. IARC monograph on the evaluation of the carcinogenic risks of chemicals to humans
94. Leaf composition and physical properties in relation to smoking quality and aroma
95. Chemical and sensory aspects of tobacco flavor
96. Toxicological evaluation of flavor ingredients added to cigarette tobacco: 13-week inhalation exposures in rats
97. Chemical and biological studies of a cigarette that heats rather than burns tobacco
98. Cigarette smoke composition. Part 1. Limitations of FTC method when applied to cigarettes that heat instead of burn tobacco
99. Cigarette smoke composition. Part 2. Method for determining major components in smoke of cigarettes that heat instead of burn tobacco
100. Chemical and biological studies of a new cigarette that primarily heats tobacco. Part 1. Chemical composition of mainstream smoke
101. Chemical and biological studies of a new cigarette that primarily heats tobacco. Part II. In vitro toxicology of mainstream smoke condensate
102. Chemical and biological studies of a new cigarette that primarily heats tobacco. III. In vitro toxicology of whole smoke
103. A safer cigarette?
104. Comparative study of DNA adduct formation in mice following dermal application of smoke condensate from cigarettes that burn or primarily heat tobacco
105. Human smoking behavior study. ECLIPSE cigarette compared to usual brand
106. Nicotine content of the Eclipse nicotine delivery device
107. Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco
108. Strain differences in the response of inbred Syrian hamsters to cigarette smoke inhalation
109. Glass fiber contamination of cigarette filters: An additional health risk to the smoker?
110. Massachusetts disputes claims about eclipse cigarettes
111. Policy committee urges regulation on eclipse
112. Evaluation of the electrically heated cigarette. S. O. T. 1998 annual meeting
113. The changing cigarette
114. The tobacco epidemic. A global public health emergency. Tobacco or health programme on substance abuse
115. Nicotine regulation and cigarette smoking
116. Low-tar medium-nicotine cigarettes. A new approach to safer smoking
117. The case for medium-nicotine, low-tar, low-carbon monoxide cigarettes
118. Relation of nicotine yield of cigarettes to blood nicotine level in smokers
119. Estimating the yields to smokers of tar, nicotine, and carbon monoxide from the lowest yield ventilated cigarettes
120. Smokers of low-yield cigarettes do not consume less nicotine
121. Cigarette smoking as a risk factor for cardiovascular disease. VI. Compensation with nicotine availability as a single variable
122. Puffvolume increases when low-nicotine cigarettes are smoked
123. Smoking behavior among participants in the nurses' health study
124. Risk of lung cancer in smokers who switched to filter cigarettes
125. The epidemiology of lung cancer. Recent trends
126. "Tar" and nicotine content of cigarette smoke in relation to death rate
127. Smoking and health. The association between smoking behavior, total mortality and cardiorespiratory disease in West Central Scotland
128. Impact of long-term filter cigarette usage on lung and larynx cancer risk. A case control study
129. The effect of filters on the incidence of lung cancer in cigarette smokers
130. Changes in bronchial epithelium in relation to cigarette smoking: 1955-1960 vs. 1970-1977
131. Pharmacological and physiological determinants of smoking
132. Effects of nicotine-enriched cigarette on nicotine titration, daily cigarette consumption, and levels of carbon monoxide, cotinine, and nicotine
133. Smoking behavior in Germany. The analysis of cigarettes
134. Puffing frequency and nicotine intake in cigarette smokers
135. The misuse of less hazardous cigarettes and its detection of holeblocking of ventilated filters
136. Compensation for nicotine by smokers of low-yield cigarettes
137. Cigarette brand-switching: Effects on smoke exposure and smoking behavior
138. Ultralow-yield cigarettes: The role of ventilation blocking
139. Mouth insertion depths in Canadian smokers
140. The incidence and consequences of filter vent blocking amongst British smokers
141. Biomarkers of cigarette smokers
142. Reduced tar, nicotine, and carbon monoxide exposure while smoking ultra low- but not low-yield cigarettes
143. Analytical cigarette yields as predictors of some bioavailability
144. Micro-computer-aided measurements of puff parameters during smoking of low- and medium-tar cigarettes
145. Self-regulation of smoking intensity. Smoke yields of the lownicotine, low-"tar" cigarettes
146. Doses of nicotine and lung carcinogens delivered to cigarette smokers
147. It's time for a change: Cigarette smokers deserve meaningful information about their cigarettes
148. Response to correspondence: "It's time for a change: Cigarette smokers deserve meaningful information about their cigarettes"
149. Correspondence: "It's time for a change: Cigarette smokers deserve meaningful information about their cigarettes"
150. Smoking and lung cancer. Some unresolved issues
151. Smoking and lung cancer: Risk as a function of cigarette tar content
152. The effect of the low-yield cigarette smoking and lung cancer risk
153. A prospective study of cigarette tar yield and lung cancer
154. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking
155. Changes in cigarette-related diseases, risks, and their implications for prevention and control, NCI
156. Changes in mortality from smoking in two American cancer society prospective studies since 1959
157. Cigarette smoking and histopathology of lung cancer
158. The past, present, and future of the prevention of lung cancer
159. Lung cancer mortality rates in birth cohorts in the United States from 1960 to 1994
160. Cancer incidence and morbidity in the United States, 1973-1977
161. Comparative epidemiology of tobacco-related caners
162. The changing histopathology of lung cancer
163. Significant changes in the distribution of histologic types of lung cancer. A review of 4,928 cases
164. Cigarette smoking among adults in the United States, 1997
165. Bronchiogenic carcinoma in Olmsted County, 1935-1979
166. Third national cancer survey: Incidence data
167. Changing patterns of lung cancer incidence by histologic type
168. Smoking and lung cancer. Scientific challenges and opportunities
169. The changing pattern of lung carcinoma
170. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines
171. Establishing a nicotine threshold for addiction: The implications for tobacco regulation
172. Zur entstehung carcinogener nitrosamine am beispiel des tabakrauches
173. Zur bestimmung des nornikotins im rauchkondensat von nornikotin reichen zigaretten
174. Artifact formation during smoke trapping: An improved method for determining N-nitrosamines in cigarette smoke
175. The nitrosation of nicotine: A kinetic study
176. Formation of tobacco-specific nitrosamines in flue-cured tobacco
177. Evaluation of the evidence that tobacco-specific nitrosamines (TSNA) cause cancer in humans
178. Chemical composition and carcinogenicity of smokeless tobacco
179. Effect of storage conditions on nitrosated, acylated, and oxidized pyridine alkaloid derivatives in smokeless tobacco products
180. Effects of storage conditions on levels of tobacco-specific N-nitrosamines and N-nitrosamino acids in U. S. moist snuff
181. Curing the TSNA problem
182. Chemical studies on tobacco smoke. LII. Origin in tobacco smoke of N′-nitrosonornicotine, a tobacco-specific carcinogen. Brief communication
183. Chemical studies on tobacco smoke. LXXIII. On the formation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone during smoking
184. Endogenous formation of N-nitrosoproline in cigarette smokers
185. Increase in the levels of N-nitrosoproline, N-nitrosothioproline, and N-nitroso-2-methylthioproline in human urine by cigarette smoking
186. The occurrence of tobacco-specific nitrosamines in oral tobacco products and their potential formation under simulated gastric conditions
187. Tobacco-specific N-nitrosamines in the saliva of habitual male snuff dippers
188. Chronic infection and inflammatory process as cancer risk factors. Possible role of nitric oxide in carcinogenesis
189. Structure and activity of acetylcholine
190. The configuration of nicotine. A nuclear magnetic resonance study
191. Pharmacological significance of nicotine
192. 3H-nicotine to rat brain membranes and its inhibition by analogues of nicotine